Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CXCL8 elevation
i
Other names:
CXCL8, 3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1, Chemokine (C-X-C motif) ligand 8
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3576
Related biomarkers:
Expression
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CXCL8 elevation
Hepatocellular Cancer
CXCL8 elevation
Hepatocellular Cancer
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
cabozantinib tablet
Resistant: B - Late Trials
cabozantinib tablet
Resistant
:
B
CXCL8 elevation
Gastric Cancer
CXCL8 elevation
Gastric Cancer
nivolumab + ramucirumab
Sensitive: C3 – Early Trials
nivolumab + ramucirumab
Sensitive
:
C3
nivolumab + ramucirumab
Sensitive: C3 – Early Trials
nivolumab + ramucirumab
Sensitive
:
C3
CXCL8 elevation
Urothelial Cancer
CXCL8 elevation
Urothelial Cancer
atezolizumab
Resistant: C3 – Early Trials
atezolizumab
Resistant
:
C3
atezolizumab
Resistant: C3 – Early Trials
atezolizumab
Resistant
:
C3
CXCL8 elevation
Renal Cell Carcinoma
CXCL8 elevation
Renal Cell Carcinoma
atezolizumab
Resistant: C3 – Early Trials
atezolizumab
Resistant
:
C3
atezolizumab
Resistant: C3 – Early Trials
atezolizumab
Resistant
:
C3
CXCL8 elevation
Cervical Cancer
CXCL8 elevation
Cervical Cancer
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
CXCL8 elevation
Non Small Cell Lung Cancer
CXCL8 elevation
Non Small Cell Lung Cancer
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
CXCL8 elevation
Head and Neck Cancer
CXCL8 elevation
Head and Neck Cancer
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
cetuximab
Resistant: C3 – Early Trials
cetuximab
Resistant
:
C3
CXCL8 elevation
Clear Cell Renal Cell Carcinoma
CXCL8 elevation
Clear Cell Renal Cell Carcinoma
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
CXCL8 elevation
Diffuse Large B Cell Lymphoma
CXCL8 elevation
Diffuse Large B Cell Lymphoma
axicabtagene ciloleucel
Resistant: C3 – Early Trials
axicabtagene ciloleucel
Resistant
:
C3
axicabtagene ciloleucel
Resistant: C3 – Early Trials
axicabtagene ciloleucel
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.